Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100.

Markus Moehler,Mikhail Dvorkin,Narikazu Boku,Mustafa Ozguroglu,Min-Hee Ryu,Alina Muntean,Sara Lonardi,Marina Nechaeva,Arinilda Bragagnoli,Hasan Senol Coskun,Antonio Cubillo Gracian,Toshimi Takano,Rachel Wong,Howard Safran,Gina M. Vaccaro,Zev A. Wainberg,Matthew R. Silver,Huiling Xiong,Janet Hong,Julien Taieb,Yung-Jue Bang

Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100.

2020

PURPOSEThe role of maintenance therapy for gastric (GC) or gastroesophageal junction cancer (GEJC) is unclear. We investigated avelumab (anti–programmed death ligand-1 [PD-L1]) maintenance after fi...

Keywords:

Cancer
Induction chemotherapy
Medicine
MEDLINE
Javelin
Internal medicine
Oncology
in patient
Chemotherapy
Avelumab
Maintenance therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations